PRO-NOVELTY: Patient-Reported Outcomes in NOse VEstibule interventionaL radioTherapY (brachytherapy)
Authors:
- Luca TagliaferriLTLuca Tagliaferri
- Elisabetta SciurtiESElisabetta Sciurti
- Bruno FiondaBFBruno Fionda
- Antonella LoperfidoALAntonella Loperfido
- Valentina LancellottaVLValentina Lancellotta
- Elisa PlacidiElisa Placidi
- Claudio ParrillaCPClaudio Parrilla
- Maria Concetta La MiliaMMMaria Concetta La Milia
- Enrico RosaEREnrico Rosa
- Mario RiganteMRMario Rigante
- Martina De AngeliMAMartina De Angeli
- Patrizia CornacchionePCPatrizia Cornacchione
Open Access
- 9 August 2024
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (16) , 4683
Abstract
Background: The aim of this paper is to evaluate the impact on the quality of life of the treatment of nasal vestibule tumors by interventional radiotherapy (IRT-brachytherapy) through a patient reported outcome questionnaire. Methods: We prospectively collected data about patients undergoing IRT according to our institutional schedule of 44 Gy delivered in 14 fractions twice a day. We recorded both acute toxicity data, using the Common Terminology Criteria for Adverse Events (CTCAE) version 5.0, and quality of life data, using the 22-item Sino-Nasal Outcome Test (SNOT-22) at baseline (T0), at 1 month (T1), at 3 months (T3), and at 6 months (T6). Results: We enrolled 10 consecutive patients treated between February 2023 and October 2023. The decrease in terms of SNOT-22 mean value was statistically significant from T0 and T6 with a p-value < 0.001. A noteworthy clinical finding is that quality of life improved regardless of the occurrence of G1-G2 side effects. Conclusions: Using SNOT-22 on patients with nasal vestibule carcinoma treated with IRT has shown an improvement in quality of life that is not strictly dependent on the occurrence of expected G1-G2 side effects.Keywords
This publication has 64 references indexed in Scilit:
- Squamous cell carcinoma of the nasal vestibule in the Netherlands: A clinical and epidemiological review of 763 cases (2008–2021)Head & Neck, 2024
- SNOT‐22 subdomain outcomes following treatment for sinonasal malignancy: A prospective, multicenter studyInternational Forum of Allergy & Rhinology, 2024
- Predictive factors for decreased baseline quality of life in patients with sinonasal malignanciesInternational Forum of Allergy & Rhinology, 2023
- Long‐term quality of life after treatment in sinonasal malignancy: A prospective, multicenter studyInternational Forum of Allergy & Rhinology, 2023
- SNOT‐22 quality of life domains differentially predict treatment modality selection in chronic rhinosinusitisInternational Forum of Allergy & Rhinology, 2014
- Outcome in squamous cell carcinoma of the nasal vestibule: A single center experienceHead & Neck, 2013
- Squamous cell carcinoma of the nasal vestibule 1993–2002: A nationwide retrospective study from DAHANCAHead & Neck, 2009
- Clinical Predictors of Quality of Life in Patients With Head and Neck CancerJAMA Otolaryngology–Head & Neck Surgery, 2004
- Impairment of nasal mucociliary clearance after radiotherapy for childhood head cancerHead & Neck, 2001
- Treatment of carcinoma of the nasal vestibule by irradiationCancer, 1976